CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Income Statement [Abstract]
Revenue	$ 56,311	$ 42,314
Costs and expenses:
Cost of revenue	10,218	7,572
Research and development	17,699	12,150
Marketing and sales	2,908	2,757
General and administrative	2,614	2,280
Total costs and expenses	33,439	24,759
Income (loss) from operations	22,872	17,555
Interest and other income (expense), net	(1,120)	827
Income before income taxes	21,752	18,382
Provision (benefit) for income taxes	(5,021)	1,738
Net income	$ 26,773	$ 16,644
Earnings per share:
Basic (in dollars per share)	$ 10.57	$ 6.59
Diluted (in dollars per share)	$ 10.44	$ 6.43
Weighted-average shares used to compute earnings per share:
Basic (in shares)	2,534	2,527
Diluted (in shares)	2,564	2,590

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Cash flows from operating activities
Net income	$ 26,773	$ 16,644
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	5,999	3,900
Share-based compensation	6,032	4,147
Deferred income taxes	123	(993)
Unrealized (gain) loss on equity investments	1,075	(135)
Other	(17)	(96)
Changes in assets and liabilities:
Accounts receivable	2,128	2,804
Prepaid expenses and other current assets	(2,424)	360
Other assets	(1,082)	(52)
Accounts payable	(937)	(1,034)
Accrued expenses and other current liabilities	(271)	(2,231)
Other liabilities	(5,173)	712
Net cash provided by operating activities	32,226	24,026
Cash flows from investing activities
Purchases of property and equipment	(18,997)	(12,941)
Purchases of marketable securities	(32,978)	(11,763)
Sales and maturities of marketable securities	19,176	4,784
Purchases of non-marketable equity investments	(544)	(100)
Payments for held-for-sale assets	(118)	0
Acquisitions of businesses and intangible assets	(372)	(1)
Other investing activities	155	11
Net cash used in investing activities	(33,678)	(20,010)
Cash flows from financing activities
Taxes paid related to net share settlement of equity awards	(4,423)	(4,883)
Repurchases of Class A common stock	0	(12,754)
Payments for dividends and dividend equivalents	(1,346)	(1,329)
Principal payments on finance leases	(843)	(751)
Other financing activities	59	222
Net cash used in financing activities	(6,553)	(19,495)
Effect of exchange rate changes on cash, cash equivalents, restricted cash, and restricted cash equivalents	7	112
Net decrease in cash, cash equivalents, restricted cash, and restricted cash equivalents	(7,998)	(15,367)
Cash, cash equivalents, restricted cash, and restricted cash equivalents at beginning of the period	39,100	45,438
Cash, cash equivalents, restricted cash, and restricted cash equivalents at end of the period	31,102	30,071
Reconciliation of cash, cash equivalents, restricted cash, and restricted cash equivalents to the condensed consolidated balance sheets
Cash and cash equivalents	23,426	28,750
Restricted cash and restricted cash equivalents, included in prepaid expenses and other current assets	340	71
Restricted cash and restricted cash equivalents, included in other assets	7,336	1,250
Total cash, cash equivalents, restricted cash, and restricted cash equivalents	31,102	30,071
Supplemental cash flow data
Cash paid for income taxes, net	541	448
Cash paid for interest, net of amounts capitalized	284	352
Non-cash investing and financing activities:
Property and equipment in accounts payable and accrued expenses and other current liabilities	16,040	9,338
Acquisition of businesses and intangible assets in accounts payable, accrued expenses and other current liabilities, and other liabilities	2,169	159
Repurchases of Class A common stock in accrued expenses and other current liabilities	$ 0	$ 577

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Mar. 31, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 23,426	$ 35,873
Marketable securities	57,754	45,719
Accounts receivable, net	17,470	19,769
Prepaid expenses and other current assets	11,115	7,361
Total current assets	109,765	108,722
Non-marketable equity investments	28,410	27,524
Property and equipment, net	194,776	176,400
Operating lease right-of-use assets	23,268	20,404
Goodwill	24,748	24,534
Other assets	14,283	8,437
Total assets	395,250	366,021
Current liabilities:
Accounts payable	13,326	8,894
Operating lease liabilities, current	2,414	2,213
Accrued expenses and other current liabilities	31,013	30,729
Total current liabilities	46,753	41,836
Operating lease liabilities, non-current	25,607	22,940
Long-term debt	58,748	58,744
Long-term income taxes	16,849	21,005
Other liabilities	3,612	4,253
Total liabilities	151,569	148,778
Commitments and contingencies
Stockholders' equity:
Common stocks and additional paid-in capital	99,337	95,793
Accumulated other comprehensive income (loss)	(303)	271
Retained earnings	144,647	121,179
Total stockholders' equity	243,681	217,243
Total liabilities and stockholders' equity	$ 395,250	$ 366,021